Efavirenz plasma concentrations and cytochrome 2B6 polymorphisms - Wikidata - awgldk - TriplyDB

Efavirenz plasma concentrations and cytochrome 2B6 polymorphisms

Efavirenz plasma concentrations and cytochrome 2B6 polymorphisms

http://www.wikidata.org/entity/Q28293288

about

Neurological and psychiatric adverse effects of antiretroviral drugs.Worldwide variation in human drug-metabolism enzyme genes CYP2B6 and UGT2B7: implications for HIV/AIDS treatment.A single-nucleotide polymorphism in CYP2B6 leads to >3-fold increases in efavirenz concentrations in plasma and hair among HIV-infected women.Pharmacogenetic markers of CYP2B6 associated with efavirenz plasma concentrations in HIV-1 infected Thai adults.Efavirenz-mediated induction of omeprazole metabolism is CYP2C19 genotype dependent.CYP2B6 genotype, but not rifampicin-based anti-TB cotreatments, explains variability in long-term efavirenz plasma exposure.The pharmacological challenges of treating tuberculosis and HIV coinfections.High plasma efavirenz level and CYP2B6*6 are associated with efavirenz-based HAART-induced liver injury in the treatment of naïve HIV patients from Ethiopia: a prospective cohort study

P2860

Q34039419-FD266D9D-E525-4D6B-8768-45A99C809B4C Q36079108-17961DEB-70F8-4F0F-BE2B-B36F4985D586 Q36305444-A59C7B0E-D9A9-4D4B-B058-47A4D1C7A002 Q36468146-0F5C910B-2269-46C6-9721-4BBFE91D3384 Q37086418-0AAF4F78-1059-458C-BB37-064CA82C5CB8 Q38861140-799EC6E3-C42C-421C-A630-5FED593F1EF9 Q39003762-A5941D10-72AC-46ED-B5DE-AE22D6892974 Q56829831-BD3BFF01-A35F-40F3-B74E-AD31EC672623

P2860

Efavirenz plasma concentrations and cytochrome 2B6 polymorphisms

http://www.wikidata.org/entity/Q28293288

description

2010 nî lūn-bûn

@nan

2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Efavirenz plasma concentrations and cytochrome 2B6 polymorphisms

@ast

Efavirenz plasma concentrations and cytochrome 2B6 polymorphisms

@en

Efavirenz plasma concentrations and cytochrome 2B6 polymorphisms

@nl

type

label

Efavirenz plasma concentrations and cytochrome 2B6 polymorphisms

@ast

Efavirenz plasma concentrations and cytochrome 2B6 polymorphisms

@en

Efavirenz plasma concentrations and cytochrome 2B6 polymorphisms

@nl

prefLabel

Efavirenz plasma concentrations and cytochrome 2B6 polymorphisms

@ast

Efavirenz plasma concentrations and cytochrome 2B6 polymorphisms

@en

Efavirenz plasma concentrations and cytochrome 2B6 polymorphisms

@nl

P1433

Q28293288-F37C3CCA-BB6E-4934-B976-DFA3A2E13B6B

P1476

Q28293288-2B0BF6A1-7A0C-4561-93B7-BDFE67E1DF39

P2093

Q28293288-3AF0C852-0B2A-4D0C-93D9-157584BE38C5

Q28293288-3E64DA8E-CA54-4E1C-ADC7-5E7759932CEE

Q28293288-460411C1-B3EA-416F-97A9-F6F59066295E

Q28293288-977783BE-4AA4-4110-8F80-7015E055C03D

Q28293288-E246848F-17E2-45BB-AA4D-CA040DB21C27

P2860

Q28293288-0BA99061-FEAB-4946-83F6-AADD66393355

Q28293288-0C448E7A-0C67-4BFA-ABE7-8846FBB5A59E

Q28293288-377472DF-9D97-4039-ADF4-95518866ED0F

Q28293288-48CCD6CF-329B-4866-AAAF-B5A3DD37C3C7

Q28293288-5233C890-774A-4F0E-A621-BCBE5D919ED5

Q28293288-660F5848-AEFD-41BF-9AC6-B0564E89BCAA

Q28293288-709630C0-0125-469D-ADBD-039BBF0AD078

Q28293288-76F86D69-E3EE-442F-A573-B84C7AAC0778

Q28293288-92B69D87-E122-4651-9476-8526237989C2

Q28293288-949ACEE0-A6CE-47D4-8216-FEF3E8A66EC8

P304

Q28293288-33CEF2DE-BE3F-4879-81E3-26BB1EB29CA9

P31

Q28293288-E6693BC2-EDE0-4A9D-B20C-51E8FE0D40A5

P356

Q28293288-BE45A4E2-7EAC-4A08-8B3D-EA49637066F0

P407

Q28293288-22664BB0-FF63-4319-94DC-BC5A24F78A7F

P433

Q28293288-2795A45D-9FA3-47D2-99CA-61477D1A53DA

P478

Q28293288-12C50B46-0EFF-4031-BBC4-BE7A2DF97364

P577

Q28293288-E1E188C4-9692-464D-A52A-DE0360CCCA3E

P698

Q28293288-AC9F495A-FFA8-4D51-B15F-6D41917E9DFD

P356

P1433

Annals of Pharmacotherapy

P1476

Efavirenz plasma concentrations and cytochrome 2B6 polymorphisms

@en

P2093

Dean L Winslow

http://www.w3.org/2001/XMLSchema#string

Jessica C Song

http://www.w3.org/2001/XMLSchema#string

John O'Brien

http://www.w3.org/2001/XMLSchema#string

Rajul Patel

http://www.w3.org/2001/XMLSchema#string

Tristan Lindfelt

http://www.w3.org/2001/XMLSchema#string

P2860

The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research

PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing

Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients.

Predictive value of known and novel alleles of CYP2B6 for efavirenz plasma concentrations in HIV-infected individuals.

Estimation of HIV incidence in the United States.

Genetic variability of CYP2B6 polymorphisms in four southern Chinese populations.

Prevalence of CYP2B6 alleles in malaria-endemic populations of West Africa and Papua New Guinea

Interpatient variability in the pharmacokinetics of the HIV non-nucleoside reverse transcriptase inhibitor efavirenz: the effect of gender, race, and CYP2B6 polymorphism

The cytochrome P450 2B6 (CYP2B6) is the main catalyst of efavirenz primary and secondary metabolism: implication for HIV/AIDS therapy and utility of efavirenz as a substrate marker of CYP2B6 catalytic activity.

Hepatic CYP2B6 expression: gender and ethnic differences and relationship to CYP2B6 genotype and CAR (constitutive androstane receptor) expression.

P304

1572-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1345/APH.1P141

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

44

http://www.w3.org/2001/XMLSchema#string

P577

2010-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20841522

http://www.w3.org/2001/XMLSchema#string